Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philip E Thompson

Showing results (1-10 of 124) with videos related to

Pageof 13
Sort By:
Trends in Pharmacological Sciences|May 23, 2024
Defeating MYC with drug combinations or dual-targeting drugsPhilip E Thompson, Jake Shortt
Frontiers in Pharmacology|October 26, 2020
IRAP Inhibitors: M1-Aminopeptidase Family InspirationNicholas Barlow, Philip E Thompson
Bioorganic & Medicinal Chemistry Letters|May 6, 2004
PDE2 inhibition by the PI3 kinase inhibitor LY294002 and analoguesBelinda M Abbott, Philip E Thompson
Bioorganic & Medicinal Chemistry Letters|November 18, 2005
Analysis of anti-PDE3 activity of 2-morpholinochromone derivatives reveals multiple mechanisms of anti-platelet activityBelinda M Abbott, Philip E Thompson
Analytical Biochemistry|March 16, 2005
A reversed-phase HPLC-based method for the assay of cyclic nucleotide phosphodiesterase activityBelinda M Abbott, Philip E Thompson
Current Topics in Medicinal Chemistry|February 20, 2007
Re-discovering PDE3 inhibitors--new opportunities for a long neglected targetPhilip E Thompson, Vincent Manganiello, Eva Degerman
RSC Medicinal Chemistry|April 27, 2026
Diverse ring architectures of cyclic peptidomimetics targeting melanocortin receptorsWenxiao K Yue, Nicholas Barlow, Philip E Thompson
Journal of Personalized Medicine|November 27, 2021
Molecular Mechanisms of Cereblon-Interacting Small Molecules in Multiple Myeloma TherapyMatteo Costacurta, Jackson He, Philip E Thompson, et al.
Chemistry & Biology|March 2, 2010
Inflammatory twins from PI3K gang brought to justice?Philip E Thompson, Ian G Jennings, Jo-Anne Pinson
Journal of Medicinal Chemistry|May 13, 2005
The next generation of phosphodiesterase inhibitors: structural clues to ligand and substrate selectivity of phosphodiesterasesDavid T Manallack, Richard A Hughes, Philip E Thompson
Pageof 13

Showing results (1-10 of 124) with videos related to

Sort By:
Pageof 13
Trends in Pharmacological Sciences|May 23, 2024
Defeating MYC with drug combinations or dual-targeting drugsPhilip E Thompson, Jake Shortt
Frontiers in Pharmacology|October 26, 2020
IRAP Inhibitors: M1-Aminopeptidase Family InspirationNicholas Barlow, Philip E Thompson
Bioorganic & Medicinal Chemistry Letters|May 6, 2004
PDE2 inhibition by the PI3 kinase inhibitor LY294002 and analoguesBelinda M Abbott, Philip E Thompson
Bioorganic & Medicinal Chemistry Letters|November 18, 2005
Analysis of anti-PDE3 activity of 2-morpholinochromone derivatives reveals multiple mechanisms of anti-platelet activityBelinda M Abbott, Philip E Thompson
Analytical Biochemistry|March 16, 2005
A reversed-phase HPLC-based method for the assay of cyclic nucleotide phosphodiesterase activityBelinda M Abbott, Philip E Thompson
Current Topics in Medicinal Chemistry|February 20, 2007
Re-discovering PDE3 inhibitors--new opportunities for a long neglected targetPhilip E Thompson, Vincent Manganiello, Eva Degerman
RSC Medicinal Chemistry|April 27, 2026
Diverse ring architectures of cyclic peptidomimetics targeting melanocortin receptorsWenxiao K Yue, Nicholas Barlow, Philip E Thompson
Journal of Personalized Medicine|November 27, 2021
Molecular Mechanisms of Cereblon-Interacting Small Molecules in Multiple Myeloma TherapyMatteo Costacurta, Jackson He, Philip E Thompson, et al.
Chemistry & Biology|March 2, 2010
Inflammatory twins from PI3K gang brought to justice?Philip E Thompson, Ian G Jennings, Jo-Anne Pinson
Journal of Medicinal Chemistry|May 13, 2005
The next generation of phosphodiesterase inhibitors: structural clues to ligand and substrate selectivity of phosphodiesterasesDavid T Manallack, Richard A Hughes, Philip E Thompson
Pageof 13